Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Do not call
En
Jubilant Pharmova Ltd. Share Price
Day's Range
Low
₹960.80
High
₹982.20
Price Summary
| Previous Close | ₹964.10 |
|---|---|
| Day's Range | ₹960.80 - ₹982.20 |
| Open | ₹976.50 |
| 52 Week Range | ₹786.05 - ₹1,162.00 |
| Volume | 54,761 |
| Market Cap | ₹0.02 |
| Previous Close | ₹965.10 |
|---|---|
| Day's Range | ₹960.80 - ₹982.00 |
| Open | ₹979.25 |
| 52 Week Range | ₹783.75 - ₹1,174.90 |
| Volume | 1,634 |
| Market Cap | ₹0.02 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 530.96 |
|---|---|
| Market Cap (₹ in Mn) | 0.02 |
| Dividend Yield(%) | 0.52 |
| Price/Earning (TTM) | 43.66 |
| TTM EPS (₹) | 22.11 |
| P/E Ratio | 32.37 |
| Book Value(₹) | 2.16 |
| PAT Margin (%) | 4.55 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 8.69 |
| Trade Value ( ₹ in Lacs) | 15.84 |
|---|---|
| Market Cap (₹ in Mn) | 0.02 |
| Dividend Yield(%) | 0.52 |
| Price/Earning (TTM) | 43.66 |
| TTM EPS (₹) | 22.11 |
| P/E Ratio | 32.37 |
| Book Value(₹) | 2.16 |
| PAT Margin (%) | 4.55 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 8.69 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 664.0 | 2314.0 |
| Expenses | N/A | N/A |
| PBT | 85.0 | 414.0 |
| Operating profit | 0.0 | 0.0 |
| Net profit | -64.0 | 192.0 |
About Jubilant Pharmova Ltd.
| Founded | 1978 |
|---|---|
| Managing Director | Priyavrat Bhartia |
| NSE Symbol | JUBLPHARMA |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,51,290.91 | 1,880.90 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 3,05,014.11 | 11,489.65 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,77,333.20 | 4,662.15 | 3,672.30 - 3,672.30 |
| Laurus Labs Ltd. | 1,30,755.56 | 2,420.00 | 917.95 - 917.95 |
| Lenskart Solutions Ltd. | 1,26,550.66 | 726.30 | 0.00 - 0.00 |
| Apollo Hospitals Enterprise Ltd. | 1,22,439.82 | 8,515.50 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,18,802.71 | 1,191.00 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,15,016.89 | 1,377.00 | 1,101.00 - 1,101.00 |
| Cipla Ltd. | 1,12,538.81 | 1,393.00 | 1,165.70 - 1,165.70 |
| Mankind Pharma Ltd. | 1,09,622.17 | 2,654.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Natco Pharma - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 8545.00 | 12643.00 | -32.41 | 14511.00 | 24570.00 | -40.94 | 35946.00 | 40945.00 | -12.21 |
| Other Income | 403.00 | 933.00 | -56.81 | 886.00 | 1529.00 | -42.05 | 2811.00 | 3213.00 | -12.51 |
| PBIDT | 2566.00 | 6458.00 | -60.27 | 4109.00 | 12451.00 | -67.00 | 15860.00 | 24656.00 | -35.67 |
| Interest | 156.00 | 117.00 | 33.33 | 252.00 | 143.00 | 76.22 | 323.00 | 196.00 | 64.80 |
| PBDT | 2410.00 | 6341.00 | -61.99 | 3857.00 | 12308.00 | -68.66 | 15537.00 | 24460.00 | -36.48 |
| Depreciation | 440.00 | 481.00 | -8.52 | 867.00 | 1019.00 | -14.92 | 1896.00 | 2200.00 | -13.82 |
| PBT | 1970.00 | 5860.00 | -66.38 | 2990.00 | 11289.00 | -73.51 | 13641.00 | 22260.00 | -38.72 |
| TAX | 538.00 | 851.00 | -36.78 | 812.00 | 1639.00 | -50.46 | 826.00 | 3756.00 | -78.01 |
| Deferred Tax | 314.00 | -455.00 | -169.01 | 478.00 | -727.00 | -165.75 | -1858.00 | -319.00 | 482.45 |
| PAT | 1432.00 | 5009.00 | -71.41 | 2178.00 | 9650.00 | -77.43 | 12815.00 | 18504.00 | -30.74 |
| Equity | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 |
| PBIDTM(%) | 30.03 | 51.08 | -41.21 | 28.32 | 50.68 | -44.12 | 44.12 | 60.22 | -26.73 |
Park Medi World - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 340.54 | 229.69 | 48.26 | 675.86 | 459.38 | 47.12 | 1289.65 | 915.82 | 40.82 |
| Other Income | 41.70 | 2.00 | 1985.00 | 88.38 | 4.01 | 2103.99 | 103.35 | 20.70 | 399.28 |
| PBIDT | 54.72 | 105.50 | -48.13 | 114.24 | 211.02 | -45.86 | 627.05 | 261.09 | 140.17 |
| Interest | 17.23 | 32.97 | -47.74 | 25.83 | 65.95 | -60.83 | 127.55 | 123.43 | 3.34 |
| PBDT | 37.49 | 72.53 | -48.31 | 88.41 | 145.07 | -39.06 | 499.50 | 137.66 | 262.85 |
| Depreciation | 43.61 | 11.62 | 275.30 | 77.42 | 23.23 | 233.28 | 45.09 | 48.62 | -7.26 |
| PBT | -6.12 | 60.91 | -110.05 | 10.99 | 121.84 | -90.98 | 454.41 | 89.04 | 410.34 |
| TAX | 0.45 | 11.95 | -96.23 | 6.72 | 23.91 | -71.89 | 88.25 | 17.24 | 411.89 |
| Deferred Tax | -2.59 | -0.13 | 1892.31 | 0.24 | -0.26 | -192.31 | -24.50 | -20.83 | 17.62 |
| PAT | -6.57 | 48.96 | -113.42 | 4.27 | 97.93 | -95.64 | 366.16 | 71.80 | 409.97 |
| Equity | 863.86 | 768.80 | 12.36 | 863.86 | 768.80 | 12.36 | 863.86 | 768.80 | 12.36 |
| PBIDTM(%) | 16.07 | 45.93 | -65.02 | 16.90 | 45.94 | -63.20 | 48.62 | 28.51 | 70.55 |
KMC Speciality Hosp. - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 929.37 | 749.02 | 24.08 | 1847.14 | 1414.55 | 30.58 | 3057.68 | 2315.98 | 32.03 |
| Other Income | 14.58 | 12.44 | 17.20 | 32.66 | 20.45 | 59.71 | 50.76 | 30.86 | 64.48 |
| PBIDT | 297.61 | 220.89 | 34.73 | 600.54 | 393.41 | 52.65 | 930.02 | 599.71 | 55.08 |
| Interest | 19.31 | 20.45 | -5.57 | 39.34 | 42.09 | -6.53 | 83.07 | 94.16 | -11.78 |
| PBDT | 278.30 | 200.44 | 38.84 | 561.20 | 351.32 | 59.74 | 846.95 | 505.55 | 67.53 |
| Depreciation | 61.92 | 53.04 | 16.74 | 120.44 | 103.86 | 15.96 | 216.71 | 189.52 | 14.35 |
| PBT | 216.38 | 147.40 | 46.80 | 440.76 | 247.46 | 78.11 | 630.24 | 316.03 | 99.42 |
| TAX | 54.15 | 38.99 | 38.88 | 112.80 | 63.70 | 77.08 | 162.89 | 101.76 | 60.07 |
| Deferred Tax | -2.95 | 5.24 | -156.30 | -7.21 | -0.90 | 701.11 | 3.77 | 28.68 | -86.85 |
| PAT | 162.23 | 108.41 | 49.64 | 327.96 | 183.76 | 78.47 | 467.35 | 214.27 | 118.11 |
| Equity | 163.08 | 163.08 | 0.00 | 163.08 | 163.08 | 0.00 | 163.08 | 163.08 | 0.00 |
| PBIDTM(%) | 32.02 | 29.49 | 8.59 | 32.51 | 27.81 | 16.90 | 30.42 | 25.89 | 17.46 |
Suraksha Diagnostic informs about audio recording of earnings call
Pursuant to Regulation 30(6) and 46(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suraksha Diagnostic has informed that the audio recording of the Earnings Call held today, Friday, November 13, 2026 at 11:00 AM (IST) in relation to the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2026 and other business discussions, is available on the Company’s website at: https://www.surakshanet.com/audio/Suraksha%20-%20Q2%20&%20FY26-27%20- %20Concall-audio-recording.mp3.
The above information is a part of company’s filings submitted to BSE.
Poly Medicure submits analysts meet intimation
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Jubilant Pharmova Ltd. is ₹964.10 as of 2026-11-13.
The market capitalisation of Jubilant Pharmova Ltd. is ₹15,372.22 as of 2026-11-13.
The 1-year return of Jubilant Pharmova Ltd. is -161.90% as of 2026-11-13.
The P/E ratio of Jubilant Pharmova Ltd. is 32.37 as of 2026-11-14.
The 52-week high and low of Jubilant Pharmova Ltd. are ₹1,162.00 and ₹786.05, respectively, as of 2026-11-13.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
